Heart Disease Clinical Trials in Ohio

Showing 161-180 of 533 trials

IPSC Repository of Pediatric Cardiovascular Disease

NCT05550324

Obtain blood samples for generation and maintenance of induced pluripotent stem cells (iPSCs) and genomic/DNA sequencing for biomedical research that will improve the understanding and treatment of pediatric cardiovascular disease

Congenital Heart DiseaseHeart Diseases

Mingtao Zhao300 participantsStarted Jul 2021

Columbus, Ohio, United States

COMPLETEDPhase 332 miles

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

NCT00826280

Observe whether the administration of caffeine prior to regadenoson will affect the interpretation of test results in subjects with coronary artery disease (CAD) undergoing SPECT MPI

Coronary Artery Disease (CAD)

Astellas Pharma Inc347 participantsStarted Mar 2009

Birmingham, Alabama, United States • Huntsville, Alabama, United States • La Mesa, California, United States +22 more locations

IPSC Repository of Pediatric Cardiovascular Disease

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

Heart Disease Trials in Other Cities

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

REmodeling the Left Ventricle With Atrial Modulated Pacing

Benefits of Microcor in Ambulatory Decompensated Heart Failure

Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction

Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events

Benefits of µCor in Ambulatory Decompensated Heart Failure

Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)

Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment

FUnctional diagnoSIs of corONary Stenosis (FUSION)

Acorai Machine Learning Generalization (MLG) Study

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

Cardiovascular Risk Screening and Risk Reduction in Women Vets

Other Conditions in Ohio